EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC – Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP ® )

标题
EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC – Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP ® )
作者
关键词
EGFR, Immunohistochemistry, H-score, Targeted therapy
出版物
PATHOLOGY RESEARCH AND PRACTICE
Volume 213, Issue 12, Pages 1530-1535
出版商
Elsevier BV
发表日期
2017-09-28
DOI
10.1016/j.prp.2017.09.021

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More